What are the most common side effects of GLP-1 therapy in elderly patients
Robert Kushner Mike Haney: So getting back to that we talked about obesity as a disease, and it's a disease in some part because our bodies were not evolved to live in such a food-rich, calorie-rich environment
J.LuqueG
While these mechanisms work at the cellular level, the timeline for observable results varies significantly
NEW YORK August 4, 2025 Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
In May 2004, Congress followed by directing the Under Secretary of Defense Acquisition, Technology and Logistics (USD [AT&L]) to encourage DoD acquisition program managers and prime contractors (holders of direct government contracts) to make significantly more SBIR Phase III contract awards and also to present a comprehensive report by March 31, 2005